Complement C5 inhibitors as add-on rescue treatment in severe AQP4-antibody neuromyelitis optica spectrum disorder attacks: a case series and literature review. [PDF]
Gan KX +5 more
europepmc +1 more source
Ravulizumab for treatment of paroxysmal nocturnal hemoglobinuria during pregnancy. [PDF]
Höchsmann B +15 more
europepmc +1 more source
Measurement of complement proteins may aid interpretation of pathophysiology in kidney transplant recipients with atypical hemolytic uremic syndrome. [PDF]
Miura M +4 more
europepmc +1 more source
Off-label intravitreal eculizumab for geographic atrophy: report of the first two cases. [PDF]
Jorge R +3 more
europepmc +1 more source
Case Report: Short-course defibrotide combined with eculizumab for TA-TMA. [PDF]
Yan Y +7 more
europepmc +1 more source
Atypical hemolytic uremic syndrome in a patient with thalassemia and a CFH gene mutation: a case report. [PDF]
Wu J +6 more
europepmc +1 more source
Gemcitabine-sirolimus synergy associated thrombotic microangiopathy in a renal transplant recipient with mesenteric leiomyosarcoma: A case report. [PDF]
Motla V +5 more
europepmc +1 more source
Reply to Letter: "Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring" by Saccà and Pelto Regarding "Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab". [PDF]
Gerischer L +3 more
europepmc +1 more source
A case report on the effective and safe use of ravulizumab in atypical hemolytic uremic syndrome during pregnancy. [PDF]
Alkhaldi A +4 more
europepmc +1 more source
A Case of Hemolytic Uremic Syndrome Due to a Pathogenic Variant in the DGKE Gene. [PDF]
Chelghoum S +4 more
europepmc +1 more source

